News Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Continue Reading Previous Letter to Shareholders and Corporate UpdateNext Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Related Stories News TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever News KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event News Rest Easy Pest Control Implements Internal CRM System Designed by Marketing Director to Improve Service Operations News Ciscom Corp. Announces Results of Its Annual Shareholders’ Meeting News Digital Lifestyle Expert Mario Armstrong and News Media Group, Inc. Reveal Top Tech Gifts for the Holidays in 2025 on a Nationwide Satellite Media Tour News Metavista3D Launches 3D Digital Microscope
